2 Ultra Safe Dividend Stocks to Buy Now
Historically, blue-chip dividend stocks have been good choices for periods…
Buy
52
ALGN Quote, Financials, Valuation and Earnings
Last price:
$180.86
Seasonality move
:
-0.76%
Day range:
$177.96 - $182.42
52-week range:
$141.74 - $271.59
Dividend yield:
0%
P/E ratio:
32.96x
P/S ratio:
3.39x
P/B ratio:
3.46x
Volume:
1.2M
Avg. volume:
1.1M
1-year change:
-29.46%
Market cap:
$13.1B
Revenue:
$4B
EPS (TTM):
$5.49
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.5B | $4B | $3.7B | $3.9B | $4B | |
| Revenue Growth (YoY) | 2.71% | 59.9% | -5.51% | 3.42% | 3.54% | |
| Cost of Revenues | $708.7M | $1B | $1.1B | $1.2B | $1.2B | |
| Gross Profit | $1.8B | $2.9B | $2.6B | $2.7B | $2.8B | |
| Gross Profit Margin | 71.33% | 74.26% | 70.52% | 70.09% | 70% | |
| R&D Expenses | $175.3M | $250.3M | $305.3M | $346.8M | $364.2M | |
| Selling, General & Admin | $1.2B | $1.7B | $1.7B | $1.7B | $1.8B | |
| Other Inc / (Exp) | -$11.3M | $32.9M | -$60.4M | -$32.7M | -$83M | |
| Operating Expenses | $1.4B | $2B | $2B | $2.1B | $2.1B | |
| Operating Income | $387.2M | $976.4M | $654M | $656.7M | $671.8M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $378.9M | $1B | $599.1M | $641.2M | $609M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$1.4B | $240.4M | $237.5M | $196.2M | $187.6M | |
| Net Income to Company | $1.8B | $772M | $361.6M | $445.1M | $421.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $1.8B | $772M | $361.6M | $445.1M | $421.4M | |
| Basic EPS (Cont. Ops) | $22.55 | $9.78 | $4.62 | $5.82 | $5.63 | |
| Diluted EPS (Cont. Ops) | $22.41 | $9.69 | $4.61 | $5.81 | $5.62 | |
| Weighted Average Basic Share | $78.8M | $78.9M | $78.2M | $76.4M | $74.9M | |
| Weighted Average Diluted Share | $79.2M | $79.7M | $78.4M | $76.6M | $75M | |
| EBITDA | $480.7M | $1.1B | $779.8M | $799.1M | $816.8M | |
| EBIT | $387.2M | $976.4M | $654M | $656.7M | $671.8M | |
| Revenue (Reported) | $2.5B | $4B | $3.7B | $3.9B | $4B | |
| Operating Income (Reported) | $387.2M | $976.4M | $654M | $656.7M | $671.8M | |
| Operating Income (Adjusted) | $387.2M | $976.4M | $654M | $656.7M | $671.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $894.8M | $973.2M | $943.1M | $997.4M | $979.3M | |
| Revenue Growth (YoY) | 62.4% | 8.77% | -3.09% | 5.76% | -1.82% | |
| Cost of Revenues | $217.7M | $263.9M | $282.5M | $299.6M | $299.2M | |
| Gross Profit | $677.1M | $709.3M | $660.7M | $697.8M | $680.1M | |
| Gross Profit Margin | 75.67% | 72.89% | 70.05% | 69.96% | 69.45% | |
| R&D Expenses | $54.5M | $71.8M | $87.4M | $91.9M | $97.2M | |
| Selling, General & Admin | $397.1M | $439.5M | $439.7M | $451.8M | $447.6M | |
| Other Inc / (Exp) | $34.5M | -$11.3M | -$1.2M | -$141K | -$152K | |
| Operating Expenses | $451.7M | $511.3M | $527.1M | $543.7M | $544.8M | |
| Operating Income | $225.4M | $198.1M | $133.5M | $154.1M | $135.3M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $261.6M | $187.5M | $134.6M | $158.4M | $140.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $61.2M | $53.2M | $46.8M | $53.4M | $47.2M | |
| Net Income to Company | $200.4M | $134.3M | $87.8M | $105M | $93.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $200.4M | $134.3M | $87.8M | $105M | $93.2M | |
| Basic EPS (Cont. Ops) | $2.54 | $1.71 | $1.14 | $1.40 | $1.27 | |
| Diluted EPS (Cont. Ops) | $2.51 | $1.70 | $1.14 | $1.39 | $1.27 | |
| Weighted Average Basic Share | $79M | $78.7M | $76.9M | $75.2M | $73.6M | |
| Weighted Average Diluted Share | $79.8M | $79.2M | $77.1M | $75.3M | $73.6M | |
| EBITDA | $251.1M | $227.7M | $169.3M | $187.1M | $174.4M | |
| EBIT | $225.4M | $198.1M | $133.5M | $154.1M | $135.3M | |
| Revenue (Reported) | $894.8M | $973.2M | $943.1M | $997.4M | $979.3M | |
| Operating Income (Reported) | $225.4M | $198.1M | $133.5M | $154.1M | $135.3M | |
| Operating Income (Adjusted) | $225.4M | $198.1M | $133.5M | $154.1M | $135.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.8B | $4B | $3.7B | $3.9B | $4B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $769.8M | $1.1B | $1.1B | $1.2B | $1.2B | |
| Gross Profit | $2B | $3B | $2.6B | $2.7B | $2.8B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $188.3M | $267.6M | $320.9M | $351.2M | $369.5M | |
| Selling, General & Admin | $1.3B | $1.8B | $1.7B | $1.7B | $1.8B | |
| Other Inc / (Exp) | $41.7M | -$12.9M | -$50.3M | -$31.6M | -$83M | |
| Operating Expenses | $1.5B | $2B | $2B | $2.1B | $2.1B | |
| Operating Income | $542.7M | $949M | $589.5M | $677.3M | $652.9M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $587.2M | $938.3M | $546.2M | $665M | $591M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $129.1M | $232.3M | $231.1M | $202.7M | $181.5M | |
| Net Income to Company | $458.1M | $705.9M | $315.1M | $462.3M | $409.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $458.1M | $705.9M | $315.1M | $462.3M | $409.6M | |
| Basic EPS (Cont. Ops) | $5.81 | $8.95 | $4.05 | $6.09 | $5.49 | |
| Diluted EPS (Cont. Ops) | $5.75 | $8.89 | $4.05 | $6.07 | $5.49 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $641.1M | $1.1B | $721.5M | $816.8M | $804.1M | |
| EBIT | $542.7M | $949M | $589.5M | $677.3M | $652.9M | |
| Revenue (Reported) | $2.8B | $4B | $3.7B | $3.9B | $4B | |
| Operating Income (Reported) | $542.7M | $949M | $589.5M | $677.3M | $652.9M | |
| Operating Income (Adjusted) | $542.7M | $949M | $589.5M | $677.3M | $652.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $894.8M | $973.2M | $943.1M | $997.4M | $979.3M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $217.7M | $263.9M | $282.5M | $299.6M | $299.2M | |
| Gross Profit | $677.1M | $709.3M | $660.7M | $697.8M | $680.1M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $54.5M | $71.8M | $87.4M | $91.9M | $97.2M | |
| Selling, General & Admin | $397.1M | $439.5M | $439.7M | $451.8M | $447.6M | |
| Other Inc / (Exp) | $34.5M | -$11.3M | -$1.2M | -$141K | -$152K | |
| Operating Expenses | $451.7M | $511.3M | $527.1M | $543.7M | $544.8M | |
| Operating Income | $225.4M | $198.1M | $133.5M | $154.1M | $135.3M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $261.6M | $187.5M | $134.6M | $158.4M | $140.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $61.2M | $53.2M | $46.8M | $53.4M | $47.2M | |
| Net Income to Company | $200.4M | $134.3M | $87.8M | $105M | $93.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $200.4M | $134.3M | $87.8M | $105M | $93.2M | |
| Basic EPS (Cont. Ops) | $2.54 | $1.71 | $1.14 | $1.40 | $1.27 | |
| Diluted EPS (Cont. Ops) | $2.51 | $1.70 | $1.14 | $1.39 | $1.27 | |
| Weighted Average Basic Share | $79M | $78.7M | $76.9M | $75.2M | $73.6M | |
| Weighted Average Diluted Share | $79.8M | $79.2M | $77.1M | $75.3M | $73.6M | |
| EBITDA | $251.1M | $227.7M | $169.3M | $187.1M | $174.4M | |
| EBIT | $225.4M | $198.1M | $133.5M | $154.1M | $135.3M | |
| Revenue (Reported) | $894.8M | $973.2M | $943.1M | $997.4M | $979.3M | |
| Operating Income (Reported) | $225.4M | $198.1M | $133.5M | $154.1M | $135.3M | |
| Operating Income (Adjusted) | $225.4M | $198.1M | $133.5M | $154.1M | $135.3M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $960.8M | $1.1B | $942.1M | $937.4M | $1B | |
| Short Term Investments | -- | $72M | $57.5M | $35.3M | -- | |
| Accounts Receivable, Net | $657.7M | $897.2M | $859.7M | $903.4M | $995.7M | |
| Inventory | $139.2M | $230.2M | $338.8M | $296.9M | $254.3M | |
| Prepaid Expenses | $30.1M | $70.2M | $69.1M | $52.5M | $83M | |
| Other Current Assets | $61.7M | $31.5M | $16.8M | $77.3M | $81.6M | |
| Total Current Assets | $1.8B | $2.5B | $2.4B | $2.4B | $2.5B | |
| Property Plant And Equipment | $817.3M | $1.2B | $1.4B | $1.4B | $1.4B | |
| Long-Term Investments | -- | $125.3M | $42M | $8M | -- | |
| Goodwill | $444.8M | $418.5M | $407.6M | $419.5M | $442.6M | |
| Other Intangibles | $130.1M | $109.7M | $95.7M | $82.1M | $103.5M | |
| Other Long-Term Assets | $35.2M | $57.5M | $55.8M | $128.7M | $234.2M | |
| Total Assets | $4.8B | $5.9B | $5.9B | $6.1B | $6.2B | |
| Accounts Payable | $142.1M | $163.9M | $127.9M | $113.1M | $108.7M | |
| Accrued Expenses | $353.7M | $550.8M | $353.5M | $458M | $518.3M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $21.7M | $22.7M | $26.6M | $29.7M | $31.1M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $1.3B | $1.9B | $1.9B | $2.1B | $2B | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.6B | $2.3B | $2.3B | $2.5B | $2.4B | |
| Common Stock | $8K | $8K | $8K | $7K | $7K | |
| Other Common Equity Adj | $43.5M | $4.3M | -$10.3M | $21.2M | $6M | |
| Common Equity | $3.2B | $3.6B | $3.6B | $3.6B | $3.9B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $3.2B | $3.6B | $3.6B | $3.6B | $3.9B | |
| Total Liabilities and Equity | $4.8B | $5.9B | $5.9B | $6.1B | $6.2B | |
| Cash and Short Terms | $960.8M | $1.2B | $999.6M | $972.7M | $1B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.1B | $926.1M | $832.4M | $865.8M | $873M | |
| Short Term Investments | -- | $86.7M | $51.6M | $33.1M | -- | |
| Accounts Receivable, Net | $719M | $950.9M | $884.4M | $950.7M | $1.1B | |
| Inventory | $150.6M | $275.7M | $311.9M | $280.1M | $246.6M | |
| Prepaid Expenses | -- | $74.1M | $84.4M | $72.2M | $104.1M | |
| Other Current Assets | $114.3M | $32.3M | $22.5M | $70.5M | $83.2M | |
| Total Current Assets | $2.1B | $2.5B | $2.3B | $2.5B | $2.4B | |
| Property Plant And Equipment | $846.3M | $1.3B | $1.4B | $1.4B | $1.4B | |
| Long-Term Investments | -- | $107.7M | $37.4M | $3.6M | -- | |
| Goodwill | $427.6M | $412M | $414.2M | $458.2M | $457.6M | |
| Other Intangibles | $120.5M | $103.5M | $93.3M | $121.4M | $102.8M | |
| Other Long-Term Assets | $38M | $57.7M | $54.3M | $121.8M | $238.9M | |
| Total Assets | $5.1B | $5.9B | $5.9B | $6.2B | $6.1B | |
| Accounts Payable | $124.3M | $186.5M | $130.6M | $117.2M | $125.4M | |
| Accrued Expenses | $343.6M | $394.2M | $364.4M | $426.3M | $466.3M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $21.5M | $25.2M | $27.8M | $31.3M | $32M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $1.4B | $1.9B | $2B | $2B | $2B | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.7B | $2.3B | $2.4B | $2.4B | $2.3B | |
| Common Stock | $8K | $8K | $8K | $7K | $7K | |
| Other Common Equity Adj | $29M | -$5.7M | $1.8M | $18.4M | $18.2M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $3.4B | $3.7B | $3.5B | $3.8B | $3.8B | |
| Total Liabilities and Equity | $5.1B | $5.9B | $5.9B | $6.2B | $6.1B | |
| Cash and Short Terms | $1.1B | $1B | $884M | $898.9M | $873M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.8B | $772M | $361.6M | $445.1M | $421.4M | |
| Depreciation & Amoritzation | $93.5M | $108.7M | $125.8M | $142.4M | $145M | |
| Stock-Based Compensation | $98.4M | $114.3M | $133.4M | $154M | $173.7M | |
| Change in Accounts Receivable | -$139.8M | -$262.1M | $21.5M | -$104.6M | -$153.5M | |
| Change in Inventories | -$29.1M | -$112.5M | -$130.1M | $30.2M | $25.1M | |
| Cash From Operations | $662.2M | $1.2B | $568.7M | $785.8M | $738.2M | |
| Capital Expenditures | $154.9M | $401.1M | $291.9M | $177.7M | $115.6M | |
| Cash Acquisitions | -$420.8M | -$8M | -$12.3M | -$77M | -$183.4M | |
| Cash From Investing | -$231.5M | -$563.4M | -$213.3M | -$195.9M | -$254.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -$375M | -$435M | -$592.4M | -$352.9M | |
| Other Financing Activities | -$51.1M | -$108.9M | -$92.8M | -$32.6M | -$28.1M | |
| Cash From Financing | -$30.8M | -$458.3M | -$501.7M | -$598.3M | -$355.7M | |
| Beginning Cash (CF) | $551.1M | $961.5M | $1.1B | $942.4M | $938.5M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $399.9M | $150.8M | -$146.3M | -$8.5M | $127.6M | |
| Ending Cash (CF) | $961.5M | $1.1B | $942.4M | $938.5M | $1B | |
| Levered Free Cash Flow | $507.3M | $771.4M | $276.8M | $608.1M | $622.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $200.4M | $134.3M | $87.8M | $105M | $93.2M | |
| Depreciation & Amoritzation | $25.6M | $29.6M | $35.8M | $32.9M | $39.1M | |
| Stock-Based Compensation | $27.2M | $31.6M | $37.7M | $38.8M | $45M | |
| Change in Accounts Receivable | -$67.4M | -$55.5M | -$32.7M | -$69.6M | -$65.3M | |
| Change in Inventories | -$15.6M | -$49.5M | $24M | $15.6M | $7.4M | |
| Cash From Operations | $227.2M | $30.5M | $199.9M | $28.7M | $52.7M | |
| Capital Expenditures | $43.4M | $87.3M | $64.1M | $9.4M | $25.3M | |
| Cash Acquisitions | -- | -- | -- | -$77.1M | -- | |
| Cash From Investing | $4.6M | -$90.2M | -$52.8M | -$79.6M | -$25.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -$75M | -$292.4M | -- | -$201.1M | |
| Other Financing Activities | -$66.6M | -$51.5M | $19.1M | -$26.1M | -$19.6M | |
| Cash From Financing | -$53.4M | -$111.7M | -$259M | -$11.7M | -$206.8M | |
| Beginning Cash (CF) | $961.5M | $1.1B | $942.4M | $938.5M | $1B | |
| Foreign Exchange Rate Adjustment | -$7.5M | -$1.8M | $2.2M | -$9M | $8.5M | |
| Additions / Reductions | $178.3M | -$171.4M | -$111.9M | -$62.6M | -$179.4M | |
| Ending Cash (CF) | $1.1B | $926.9M | $832.7M | $866.9M | $874.1M | |
| Levered Free Cash Flow | $183.8M | -$56.8M | $135.8M | $19.3M | $27.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $458.1M | $705.9M | $315.1M | $462.3M | $409.6M | |
| Depreciation & Amoritzation | $98.4M | $112.7M | $132M | $139.5M | $151.2M | |
| Stock-Based Compensation | $102.7M | $118.7M | $139.5M | $155.1M | $179.9M | |
| Change in Accounts Receivable | -$221M | -$250.2M | $44.4M | -$141.5M | -$149.2M | |
| Change in Inventories | -$34.2M | -$146.3M | -$56.6M | $21.7M | $16.9M | |
| Cash From Operations | $879.6M | $975.9M | $738.1M | $614.5M | $762.2M | |
| Capital Expenditures | $152.3M | $445M | $268.7M | $123M | $131.5M | |
| Cash Acquisitions | -$420.8M | -$8M | -$12.3M | -$154.1M | -$106.3M | |
| Cash From Investing | -$503.2M | -$658.2M | -$175.9M | -$222.7M | -$200.6M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -$450.1M | -$652.4M | -$300M | -$554M | |
| Other Financing Activities | -$72.3M | -$93.9M | -$22.1M | -$77.8M | -$21.6M | |
| Cash From Financing | -$49.5M | -$516.6M | -$648.9M | -$351.1M | -$550.8M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $326.9M | -$199M | -$86.7M | $40.8M | $10.9M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $727.3M | $530.9M | $469.4M | $491.6M | $630.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $200.4M | $134.3M | $87.8M | $105M | $93.2M | |
| Depreciation & Amoritzation | $25.6M | $29.6M | $35.8M | $32.9M | $39.1M | |
| Stock-Based Compensation | $27.2M | $31.6M | $37.7M | $38.8M | $45M | |
| Change in Accounts Receivable | -$67.4M | -$55.5M | -$32.7M | -$69.6M | -$65.3M | |
| Change in Inventories | -$15.6M | -$49.5M | $24M | $15.6M | $7.4M | |
| Cash From Operations | $227.2M | $30.5M | $199.9M | $28.7M | $52.7M | |
| Capital Expenditures | $43.4M | $87.3M | $64.1M | $9.4M | $25.3M | |
| Cash Acquisitions | -- | -- | -- | -$77.1M | -- | |
| Cash From Investing | $4.6M | -$90.2M | -$52.8M | -$79.6M | -$25.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -$75M | -$292.4M | -- | -$201.1M | |
| Other Financing Activities | -$66.6M | -$51.5M | $19.1M | -$26.1M | -$19.6M | |
| Cash From Financing | -$53.4M | -$111.7M | -$259M | -$11.7M | -$206.8M | |
| Beginning Cash (CF) | $961.5M | $1.1B | $942.4M | $938.5M | $1B | |
| Foreign Exchange Rate Adjustment | -$7.5M | -$1.8M | $2.2M | -$9M | $8.5M | |
| Additions / Reductions | $178.3M | -$171.4M | -$111.9M | -$62.6M | -$179.4M | |
| Ending Cash (CF) | $1.1B | $926.9M | $832.7M | $866.9M | $874.1M | |
| Levered Free Cash Flow | $183.8M | -$56.8M | $135.8M | $19.3M | $27.4M | |
Get ALGN Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ALGN
Sector
P/E ratio
32.96x
24.27x
PEG ratio
1.53x
0.00x
P/B ratio
3.46x
1.75x
Price / LTM sales
3.39x
1.65x
Growth Metrics
ALGN
Sector
Revenue growth
-1.82%
4.98%
Earnings growth
-8.63%
7.49%
Revenue (5-year growth)
10.69%
8.25%
Earnings forecast
$1.99
-$0.20
Profitability
ALGN
Sector
Profitability FY 2024
$2.8B
$51.2M
Return on invested capital
10.72%
-14.95%
Return on assets
6.61%
-12.07%
Return on equity
10.72%
-17.16%
Earnings Date
Last Earnings Date
Apr
30
Next Earnings Date
Jul
30
Estimated Next Earnings Date
Jul
30
Balance Sheet
ALGN
Sector
Total cash
$873M
$38.3M
Short term investments
--
$32.2M
Total assets
$6.2B
$118.2M
Long term debt
--
$8.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Asana Stock Be in 5 Years?
Asana stock hasn’t given many investors on Wall Street any…
Where Will Dell Stock Be in 5 Years?
So you’re looking at Dell (NASDAQ: DELL) and wondering, “Is…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
31
REGN alert for May 31
Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.
Buy
55
RGC alert for May 31
Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.
Sell
42
AMBA alert for May 31
Ambarella [AMBA] is down 15.13% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
